Search results
Showing 1 to 7 of 7 results for tirzepatide
Evidence-based recommendations on tirzepatide (Mounjaro) for type 2 diabetes in adults.
In development [GID-TA11156] Expected publication date: 14 January 2025
Consultation on NHS England proposals for a phased launch of obesity injection
Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins.
In development [GID-TA11104] Expected publication date: TBC
More than 20 pieces of draft and final guidance on a range of medicines and medical conditions were published during the pre-election period.
More evidence needed to recommend Type 2 diabetes treatment tirzepatide
More evidence is needed on the clinical and cost-effectiveness of a new treatment option for people with type 2 diabetes before it could be recommended for NHS use
New treatment option recommended for people with type 2 diabetes
Around 180,000 people with difficult to manage type 2 diabetes could benefit from tirzepatide as new treatment option for type 2 diabetes.